Journal Article Review Epublish 188 citations
PubMed: 37342500 DOI: 10.3389/fmed.2023.1187163
ME/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature.
Front Med (Lausanne) 10:1187163
Authors: Anthony L Komaroff, W Ian Lipkin
Affiliations
- Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
- Center for Infection and Immunity, Mailman School of Public Health, Vagelos College of Physicians and Surgeons of Columbia University, New York, NY, United States.
Abstract
Some patients remain unwell for months after "recovering" from acute COVID-19. They develop persistent fatigue, cognitive problems, headaches, disrupted sleep, myalgias and arthralgias, post-exertional malaise, orthostatic intolerance and other symptoms that greatly interfere with their ability to function and that can leave some people housebound and disabled. The illness (Long COVID) is similar to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) as well as to persisting illnesses that can follow a wide variety of other infectious agents and following major traumatic injury. Together, these illnesses are projected to cost the U.S. trillions of dollars. In this review, we first compare the of ME/CFS and Long COVID, noting the considerable similarities and the few differences. We then compare in extensive detail the underlying of these two conditions, focusing on abnormalities of the central and autonomic nervous system, lungs, heart, vasculature, immune system, gut microbiome, energy metabolism and redox balance. This comparison highlights how strong the evidence is for each abnormality, in each illness, and helps to set priorities for future investigation. The review provides a current road map to the extensive literature on the underlying biology of both illnesses.
MeSH
Signs And Symptoms, Fatigue Syndrome, Chronic, Post-Acute Covid-19 Syndrome
Cited by
- Long read sequencing characterises a novel structural variant, revealing underactive AKR1C1 with overactive AKR1C2 as a possible cause of severe chronic fatigue. J Transl Med, 2023
- Focus on post-exertional malaise when approaching ME/CFS in specialist healthcare improves satisfaction and reduces deterioration. Front Neurol, 2023
- Similar Patterns of Dysautonomia in Myalgic Encephalomyelitis/Chronic Fatigue and Post-COVID-19 Syndromes. Pathophysiology, 2024
- Do people with ME/CFS and joint hypermobility represent a disease subgroup? An analysis using registry data. Front Neurol, 2024
- Immune exhaustion in ME/CFS and long COVID. JCI Insight, 2024
- Meta-analysis of natural killer cell cytotoxicity in myalgic encephalomyelitis/chronic fatigue syndrome. Front Immunol, 2024
- Associations between physical activity, long COVID symptom intensity, and perceived health among individuals with long COVID. Front Psychol, 2024
- Oral minocycline therapy as first-line treatment in patients with Myalgic encephalomyelitis and long COVID: A pilot study. eNeurologicalSci, 2024
- Association of circulating biomarkers with illness severity measures differentiates myalgic encephalomyelitis/chronic fatigue syndrome and post-COVID-19 condition: a prospective pilot cohort study. J Transl Med, 2024
- Two neurocognitive domains identified for patients with myalgic encephalomyelitis/chronic fatigue syndrome and post-acute sequelae of COVID-19. Front Neurol, 2025
- Knowledge Representation and Management in the Age of Long Covid and Large Language Models: a 2022-2023 Survey. Yearb Med Inform, 2025
- Language Matters: What Not to Say to Patients with Long COVID, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, and Other Complex Chronic Disorders. Int J Environ Res Public Health, 2025
- Cognitive impact and brain structural changes in long COVID patients: a cross-sectional MRI study two years post infection in a cohort from Argentina. BMC Neurol, 2024
- Case Report: The intersection of psychiatry and medicine: diagnostic and ethical insights from case studies. Front Psychiatry, 2025
- Medicinal plants for the management of post-COVID-19 fatigue: A literature review on the role and mechanisms. J Tradit Complement Med, 2025
- Repetitive transcranial magnetic stimulation ameliorates symptoms in patients with myalgic encephalomyelitis (chronic fatigue syndrome). IBRO Neurosci Rep, 2023
- Epstein-Barr virus-acquired immunodeficiency in myalgic encephalomyelitis-Is it present in long COVID? J Transl Med, 2023
- Editorial: On the cusp of the silent wave of the long COVID pandemic: why, what and how should we tackle this emerging syndrome in the clinic and population? Front Public Health, 2024
- The PACE Trial's GET Manual for Therapists Exposes the Fixed Incremental Nature of Graded Exercise Therapy for ME/CFS. Life (Basel), 2025
- Post-infection symptoms up to 24 months after COVID-19: a matched cohort study in Berlin, Germany. Front Public Health, 2025